TABLE 5.
Demographic and clinical characteristics of inpatients with ASMs prescription for SUP.
| Characteristics | Total (n = 893) | Appropriate (n = 496) | Overprescription (n = 397) | p-value |
|---|---|---|---|---|
| Age (years) | 0.001 | |||
| Median (Q1, Q3) | 45 (58, 70) | 56 (45, 67.5) | 61 (46, 73) | |
| ≤44 | 213 (23.8) | 122 (24.6) | 91 (22.9) | <0.001 |
| 45–64 | 357 (40.0) | 223 (45.0) | 134 (33.8) | |
| ≥65 | 323 (36.2) | 151 (30.4) | 172 (43.3) | |
| Gender | 0.725 | |||
| Female | 449 (50.3) | 252 (50.8) | 197 (49.6) | |
| Male | 444 (49.7) | 244 (49.2) | 200 (50.4) | |
| Current smokers | 0.342 | |||
| No | 737 (82.5) | 404 (81.5) | 333 (83.9) | |
| Yes | 156 (17.5) | 92 (18.5) | 64 (16.1) | |
| Alcohol consumption | 0.039 | |||
| No | 790 (88.5) | 429 (86.5) | 361 (90.9) | |
| Yes | 103 (11.5) | 67 (13.5) | 36 (9.1) | |
| Occupational status | <0.001 | |||
| Employed | 255 (28.6) | 105 (21.2) | 150 (37.8) | |
| Unemployed | 453 (50.7) | 286 (57.6) | 167 (42.1) | |
| Retired | 185 (20.7) | 105 (21.2) | 80 (20.1) | |
| Residence | 0.009 | |||
| Rural | 473 (53.0) | 282 (56.9) | 191 (48.1) | |
| Urban | 420 (47.0) | 214 (43.1) | 206 (51.9) | |
| Health insurance | 0.143 | |||
| No | 303 (33.9) | 158 (31.9) | 145 (36.5) | |
| Yes | 590 (66.1) | 338 (68.1) | 252 (63.5) | |
| Comorbidity conditions | ||||
| Hypertension | 225 (25.2) | 128 (25.8) | 97 (24.4) | 0.639 |
| Diabetes mellitus | 111 (12.4) | 58 (11.7) | 53 (13.4) | 0.456 |
| Coronary artery disease | 130 (14.6) | 55 (11.1) | 75 (18.9) | 0.001 |
| Osteoporosis | 76 (8.5) | 44 (8.9) | 32 (8.1) | 0.666 |
| Number of comorbidities | 0 (0, 1) | 0 (0, 1) | 1 (0, 2) | 0.003 |
| Complications | 127 (14.2) | 53 (10.7) | 74 (18.6) | 0.001 |
| Concurrently used drugs | ||||
| Anticoagulants | 531 (59.5) | 279 (56.3) | 252 (63.5) | 0.029 |
| Antiplatelet agents | 24 (2.7) | 16 (3.2) | 8 (2.0) | 0.266 |
| Systemic corticosteroids | 345 (38.6) | 258 (52.0) | 87 (21.9) | <0.001 |
| NSAIDs | 722 (80.9) | 389 (78.4) | 333 (83.9) | 0.040 |
| Number of drugs excluding PPIs | <0.001 | |||
| Median (Q1, Q3) | 19 (14, 28) | 21 (15.5, 29) | 16 (12, 25) | |
| 6–14 | 263 (29.5) | 102 (20.6) | 161 (40.6) | <0.001 |
| 15–19 | 212 (23.7) | 116 (23.4) | 96 (24.2) | |
| 20–28 | 217 (24.3) | 141 (28.4) | 76 (19.1) | |
| 29–59 | 201 (22.5) | 137 (27.6) | 64 (16.1) | |
| Length of hospital stay (days) | 0.172 | |||
| Median (Q1, Q3) | 10 (7, 16) | 11 (8, 15) | 10 (7, 16) | |
| 3–7 | 230 (25.8) | 111 (22.4) | 119 (30.0) | 0.011 |
| 8–10 | 224 (25.1) | 131 (26.4) | 93 (23.4) | |
| 11–16 | 244 (27.3) | 152 (30.6) | 92 (23.2) | |
| 17–54 | 195 (21.8) | 102 (20.6) | 93 (23.4) |
The data are presented as numbers (proportions) or the median (interquartile range). Bold values indicate a p-value <0.05.